While the FDA may consider an emergency use authorization, a coronavirus vaccine likely won’t be accessible to the general public until next year, says Healthcare Policy Analyst Chris Meekins.
Recorded June 24, 2020.
Markets & Investing April 01, 2024 Raymond James CIO Larry Adam reminds investors they need to be well...
Markets & Investing April 01, 2024 Market rally driven by a broadening of the market and optimism that...
Markets & Investing April 01, 2024 Doug Drabik discusses fixed income market conditions and offers...